SEAL Device

DEVICE2 trials

Sponsors

Galaxy Therapeutics INC

Conditions

AneurysmAneurysm, RupturedAneurysms Saccular

Unknown Phase

Pre-SEAL™IT: Saccular Endovascular Aneurysm Lattice System First In Human Interventional Trial

CompletedNCT05686733

Galaxy Therapeutics INCAneurysm, Aneurysm, Ruptured, Aneurysms Saccular

Start: 2022-01-26End: 2024-02-17Updated: 2024-04-04

SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry

RecruitingNCT05880680

Galaxy Therapeutics INCAneurysm, Aneurysm, Ruptured

Start: 2023-10-09End: 2030-06-15Target: 200Updated: 2025-04-04

Related Papers

Safety and efficacy of the Saccular Endovascular Aneurysm Lattice (SEAL) system for the treatment of wide neck bifurcation aneurysms: final 12 month results from the primary subgroup analysis of the Pre-SEAL First-in-Human Interventional Trial (Pre-SEAL IT).

2026-04-29